Beta Bionics Adds Pre-Funded Warrants to $125M Offering
BBNX has more than doubled off its 52-week low of $8.8.
Summary
Beta Bionics supplements its $125M offering with pre-funded warrants exercisable at $0.0001, adding a dilutive overhang but enabling broader investor participation.
Key Events · Financing and Capital Events · BBNX
-
Pre-Funded Warrants Added to Offering
Beta Bionics is offering pre-funded warrants in lieu of common stock to certain investors, with a nominal exercise price of $0.0001 per share and no expiration date.
-
Ownership Caps on Warrant Exercise
Warrant holders cannot exercise if they would own more than 4.99% (or 9.99% at election, up to 19.99% with 61 days' notice) of outstanding common stock.
-
Offering Priced at $17.25
The underlying common stock was priced at $17.25 per share on September 16, 2026, below the prior close of $18.11 and current price of $18.15.
-
Underwriting Syndicate
J.P. Morgan, Piper Sandler, Wells Fargo Securities, and Leerink Partners are acting as underwriters for the offering.
Analysis · BBNX · Industrial Applications And Services
Beta Bionics is adding pre-funded warrants to its $125 million public offering, giving certain investors an alternative to common stock. The warrants carry a nominal $0.0001 exercise price and are immediately exercisable with no expiration, meaning they function economically like common stock but with ownership caps of 4.99% to 19.99%. This structure lets investors who would otherwise hit ownership limits still participate in the raise. The offering was priced at $17.25 per share on September 16, a discount to the prior close of $18.11, and the company's stock now trades at $18.15. The addition of warrants increases the potential share count and dilution overhang, though the company will receive only nominal proceeds upon exercise.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 30% of the 1759 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.34%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BBNX was trading at $18.15 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $865.2M. The 52-week trading range was $8.80 to $32.71. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.